- Home
- RNAC vs TNYA Comparison
RNAC vs TNYA Comparison
Compare RNAC & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAC
- TNYA
- Stock Information
- Founded
- RNAC 2007
- TNYA 2016
- Country
- RNAC United States
- TNYA United States
- Employees
- RNAC N/A
- TNYA N/A
- Industry
- RNAC Biotechnology: Pharmaceutical Preparations
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- RNAC Health Care
- TNYA Health Care
- Exchange
- RNAC Nasdaq
- TNYA Nasdaq
- Market Cap
- RNAC 276.3M
- TNYA 326.0M
- IPO Year
- RNAC 2016
- TNYA 2021
- Fundamental
- Price
- RNAC $9.13
- TNYA $1.66
- Analyst Decision
- RNAC Strong Buy
- TNYA Strong Buy
- Analyst Count
- RNAC 4
- TNYA 5
- Target Price
- RNAC $40.00
- TNYA $8.60
- AVG Volume (30 Days)
- RNAC 87.6K
- TNYA 4.6M
- Earning Date
- RNAC 11-07-2025
- TNYA 11-06-2025
- Dividend Yield
- RNAC N/A
- TNYA N/A
- EPS Growth
- RNAC N/A
- TNYA N/A
- EPS
- RNAC N/A
- TNYA N/A
- Revenue
- RNAC $1,026,000.00
- TNYA N/A
- Revenue This Year
- RNAC N/A
- TNYA N/A
- Revenue Next Year
- RNAC N/A
- TNYA N/A
- P/E Ratio
- RNAC N/A
- TNYA N/A
- Revenue Growth
- RNAC N/A
- TNYA N/A
- 52 Week Low
- RNAC $8.46
- TNYA $0.36
- 52 Week High
- RNAC $26.50
- TNYA $4.01
- Technical
- Relative Strength Index (RSI)
- RNAC 42.17
- TNYA 49.55
- Support Level
- RNAC $8.75
- TNYA $1.65
- Resistance Level
- RNAC $10.17
- TNYA $2.02
- Average True Range (ATR)
- RNAC 0.58
- TNYA 0.17
- MACD
- RNAC -0.04
- TNYA -0.05
- Stochastic Oscillator
- RNAC 18.16
- TNYA 4.29
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.